Conditions: Cystic Fibrosis
Intervention Type: Drug
Intervention Name: denufosol tetrasodium (INS37217) Inhalation Solution
Clinical Trials
The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Drug" intervention "denufosol tetrasodium (INS37217) Inhalation Solution" on "Cystic Fibrosis".
-
Ph 1b/2a Study to Assess Levels of INS37217 and Placebo Treatment With Maximum Tolerated Dose Administered by Inhalation Via the Pari LC Star Nebulizer in Adult and Pediatric CF Patients
NCTID: NCT00034515
-
A Randomized, Double-Blind, Two Way Crossover Evaluation of the Effects of a Single Dose of Denufosol Tetrasodium (INS37217) Inhalation Solution Versus Placebo (0.9% Sodium Chloride Solution) on Mucociliary Clearance in Patients With Mild to Moderate Cystic Fibrosis Lung Disease
NCTID: NCT00425165